Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-24

FDA Approved: LEVALBUTEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for levalbuterol, confirming approval of the generic product under an ANDA and enabling continued marketing in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)